enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bebtelovimab - Wikipedia

   en.wikipedia.org/wiki/Bebtelovimab

   Possible side effects include itching, rash, infusion-related reactions, nausea and vomiting. [ 2 ] Bebtelovimab works by binding to the spike protein of the virus that causes COVID-19, similar to other monoclonal antibodies that have been authorized for the treatment of high-risk people with mild to moderate COVID-19 and shown a benefit in ...

3. Sotrovimab - Wikipedia

   en.wikipedia.org/wiki/Sotrovimab

   Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2, known as SARS-CoV-2. [ 10 ] [ 12 ] [ 13 ] It was developed by GlaxoSmithKline and Vir Biotechnology, Inc. [ 12 ] [ 14 ] Sotrovimab is designed to attach to the spike protein of SARS-CoV-2.

4. Casirivimab/imdevimab - Wikipedia

   en.wikipedia.org/wiki/Casirivimab/imdevimab

   It consists of two human monoclonal antibodies, casirivimab and imdevimab that must be mixed together and administered as an infusion or subcutaneous injection. [13] [8] [10] The combination of two antibodies is intended to prevent mutational escape. [14] It is also available as a co-formulated product. [13]

5. COVID Monoclonal Antibody Therapy: Everything You Need ... - AOL

   www.aol.com/news/covid-monoclonal-antibody...

   For premium support please call: 800-290-4726 more ways to reach us

6. COVID Antibody Drugs Go Unused, May Not Work on New ... - AOL

   www.aol.com/news/covid-antibody-drugs-unused-may...

   IV treatments of lab-created monoclonal antibodies are meant for the early stages of infection, to help patients in danger of getting severely sick recover from COVID-19. For Ken Wells in Arizona ...

7. COVID-19 drug development - Wikipedia

   en.wikipedia.org/wiki/COVID-19_drug_development

   Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. [102] The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion. [103] [104] The medicine is given by infusion (drip) into a vein. [102] [105] The most common side effects include infusion ...

8. Monoclonal antibody infusions? They're keeping many COVID-19 ...

   www.aol.com/news/monoclonal-antibody-infusions...

   For premium support please call: 800-290-4726 more ways to reach us

9. There's a new monoclonal antibody in town: Sotrovimab is ...

   www.aol.com/news/theres-monoclonal-antibody-town...

   Two older monoclonal antibody treatments are no longer available because they don't work on the omicron COVID variant. There's a new monoclonal antibody in town: Sotrovimab is fighting omicron in ...